drugset / Trial / NCT06591299

Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA

NCT06591299

Phase 3 Recruiting 870 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of clopidogrel administered within 24 hours of the first-ever minor stroke or TIA compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects

Timeline

Start
2022-04-15
Primary completion
2024-09-15
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilostazol Small molecule 100 mg
Comparator Clopidogrel Small molecule 75 mg

Indications